HSPG2 and acute respiratory distress syndrome: Consistent with previous researches,[13, 31] patients with S‐ARDS had significantly increased serum HSPG2 and syndecan‐1 levels compared with those in healthy donors (Figure S2J, Supporting Information), and these levels increased with ARDS exacerbation (Figure S2K, Supporting Information).